JUNS: Pangali P/E Jupiter Neurosciences
Jupiter Neurosciences Inc (JUNS) possesses robust patent protection for its brain-delivery technologies and significant influence within the US scientific community, despite strict FDA oversight. The brand has earned recognition for developing breakthrough neuroprotective agents. This price chart illustrates a P/E ratio of -0.30. The company's prospects rely on the transition to full-scale clinical trials and the pursuit of new grants.
Rincian metrik komprehensif lan analitis Jupiter Neurosciences Inc (JUNS)
- rega saham lan konsensus proyeksi valuasi:
- informasi kapitalisasi pasar:
- rincian nilai buku perusahaan:
- data liabilitas lan likuiditas perusahaan:
Utang Agregat marang Modal Jupiter Neurosciences Inc|JUNS - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal jupiterneurosciences.com|JUNS - Utang perusahaan|Rasio utang marang aset resik Jupiter Neurosciences Inc|JUNS - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Jupiter Neurosciences|Rasio likuiditas darurat jupiterneurosciences.com
- indikator pendapatan resik lan kelipatan nilai:
JUNS - Bathi resik|Bathi resik sing dikarepake Jupiter Neurosciences Inc|JUNS - Koefisien rega marang bathi|Pangali Forward P/E Jupiter Neurosciences, Inc.|JUNS - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Jupiter Neurosciences Inc|JUNS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben siji saham sajrone rolas wulan pungkasan Jupiter Neurosciences|JUNS - Bathi saben saham sajrone rolas wulan pungkasan|Owah-owahan bathi resik saben saham taun-ka-taun sajrone rolas wulan pungkasan jupiterneurosciences.com|JUNS - Wutah bathi ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep Jupiter Neurosciences Inc
Analisis komprehensif perusahaan:Jupiter Neurosciences, Inc. - JUNS
Investors are assessing the stability of Jupiter Neurosciences Inc (JUNS) via the P/E ratio, which relates market capitalization to net income to determine the investment payback period. By analyzing the relative P/E valuation of Jupiter Neurosciences Inc (JUNS), one can understand the extent to which the market prices in the efficiency of a lean team of neurobiologists, whose loyalty and scientific potential in Alzheimer's disease therapy drive the fundamental value of the business.
Perusahaan pesaing
BIIB (biogen.com) - Rasio rega pasar marang bathi resik|Koefisien rega marang bathi NBIX (Neurocrine Biosciences, Inc.)|Pangali P/E Regencell Bioscience Ltd (RGC)|Rasio rega marang bathi Axsome Therapeutics Inc AXSM|ACAD (ACADIA Corp) - Kapitalisasi marang bathi resik|Xenon Pharmaceuticals - Pangali P/E|Periode bali modal bisnis vikingtherapeutics.com VKTX|SUPN (Supernus) - Koefisien rega marang bathi|CPRX: Rasio rega pasar marang bathi resik|DNLI (Denali Therapeutics Inc) - Pangali P/E|Kapitalisasi marang bathi Harmony Corp HRMY|Rasio rega marang bathi Biohaven Ltd. (BHVN)|AMLX (amylyx.com) - Nilai perusahaan marang bathi resik|Trevi Therapeutics, Inc. - Koefisien rega marang bathi|Nilai perusahaan marang bathi resik PRAX|AVXL - Rasio rega marang bathi|CBLL (CeriBell EEG) - Pangali rega marang bathi|PRTA: Pangali P/E|Kapitalisasi marang bathi Alector (ALEC)|Koefisien rega marang bathi ANNX|Pangali P/E Omeros Corp.|Rasio rega marang bathi Neurogene Corp (NGNE)|ACIU (AC Immune Inc) - Nilai perusahaan marang bathi resik|Rasio rega marang bathi Voyager Therapeutics VYGR|neumoratx.com (NMRA) - Kapitalisasi marang bathi|SCLX - Rasio rega marang bathi|Periode bali modal bisnis Tevogen Bio Holdings Inc. TVGN|ACOG: Pangali P/E|Koefisien rega marang bathi Cognition Therapeutics Inc.|IKT (Inhibikase Therapeutics) - Pangali P/E|cassavasciences.com (SAVA) - Periode bali modal bisnis|Pangali P/E ASRT|COYA - Kapitalisasi marang bathi|Rasio rega marang bathi Vistagen VTGN|OVID: Pangali rega marang bathi|Acumen Pharmaceuticals - Pangali P/E|cervomed.com (CRVO) - Koefisien rega marang bathi|ATHE: Pangali P/E|Kapitalisasi marang bathi Clene (CLNN)|Rasio rega marang bathi PepGen Inc|Relmada Corp (RLMD) - Periode bali modal bisnis|Koefisien rega marang bathi ANVS (Annovis Bio, Inc.)|GRCE (gracetx.com) - Nilai perusahaan marang bathi resik|Pangali P/E AIFF (Firefly Neuroscience)|Periode bali modal bisnis ANEW Medical (KLTO)|NRSN - Rasio rega marang bathi|RVPH (Reviva Pharmaceuticals, Inc.) - Pangali rega marang bathi|MTVA: Pangali P/E|Koefisien rega marang bathi neuraxis.com|Rasio rega marang bathi Helius Medical Technologies, Inc.|PASG (Passage Bio Corp) - Rasio rega pasar marang bathi resik|Koefisien rega marang bathi NEUP (Neuphoria Therapeutics Inc.)|Pangali P/E Minerva (NERV)|Rasio rega marang bathi Athira Pharma, Inc. ATHA|ADXN: Pangali rega marang bathi|ALZN - Rasio rega marang bathi|Periode bali modal bisnis Cyclerion Therapeutics CYCN|protagenic.com (PTIX) - Rasio rega marang bathi|Pangali rega marang bathi KTTA|CRGT (Cortigent Inc) - Pangali P/E|Kapitalisasi marang bathi avenuetx.com ATXI|Koefisien rega marang bathi BCLI (BrainStorm Cell Therapeutics)|Pangali P/E Cara Therapeutics Inc. (CARA)|Rasio rega marang bathi Chromocell Therapeutics Corporation CHRO|Nilai perusahaan marang bathi resik ELYM|ITCI - Rasio rega marang bathi|Kapitalisasi marang bathi longboardpharma.com|Marinus Pharmaceuticals, Inc. (MRNS) - Rasio rega marang bathi|NKGN: Rasio rega pasar marang bathi resik|Koefisien rega marang bathi NRBO|Pangali P/E Sage Therapeutics Inc|Rasio rega marang bathi Synaptogenix, Inc. (SNPX)|TRVN: Kapitalisasi marang bathi resik|Pangali P/E VIGL (Vigil Neuroscience, Inc.)|Periode bali modal bisnis anewmeds.com (WENA)|CERE: Koefisien rega marang bathi
